Abbott (NYSE:ABT) and Tandem Diabetes Care (NASDAQ:TNDM) intends
to develop and commercialize integrated diabetes solutions combining
Abbott’s FreeStyle Libre, a sensor-based glucose monitoring system
with Tandem’s insulin delivery systems to provide more options for
people to manage their diabetes.
TNDM shares were up 5% premarket.
https://seekingalpha.com/news/3505752-abbott-tandem-diabetes-explore-integrated-solutions-diabetes-tndm-shares-5-percent-premarket
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.